Bone Biologics (BBLG) Net Income (2016 - 2017)

Historic Net Income for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$2.8 million.

  • Bone Biologics' Net Income rose 4105.06% to -$2.8 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$7.1 million, marking a year-over-year increase of 7275.14%. This contributed to the annual value of -$1.6 million for FY2021, which is 1172.83% up from last year.
  • According to the latest figures from Q4 2017, Bone Biologics' Net Income is -$2.8 million, which was up 4105.06% from -$2.4 million recorded in Q3 2017.
  • Bone Biologics' Net Income's 5-year high stood at $1.0 million during Q2 2017, with a 5-year trough of -$12.3 million in Q1 2016.